Kavout Log in

SURI

Simplify Propel Opportunities ETF · PSE

  • Category Multi-Asset
  • Expense Ratio 2.51%
  • Listing Date
  • Volume 37.0
  • Market Cap (AUM) $60.06M

Performance

+1.96%

1W

-13.25%

1M

-8.55%

3M

-37.47%

6M

-6.59%

YTD

-25.56%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Plains GP Holdings LP Class APAGP24.70%
  • Applied Therapeutics, Inc.APLT12.61%
  • TScan Therapeutics, Inc.TCRX7.61%
  • Madrigal Pharmaceuticals, Inc.MDGL6.27%
  • Phathom Pharmaceuticals, Inc.PHAT6.20%
  • EQUITY OTHERN/A5.04%
  • Avidity Biosciences IncRNA4.73%
  • Athira Pharma, Inc.ATHA3.44%
  • Ardelyx, Inc.ARDX3.07%
  • Fulcrum Therapeutics, Inc.FULC2.98%
Advanced Technical Analysis

Technical Analysis of SURI 2025-04-16

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 16, Oscillators Score at 37, and a Technical Score of 26, indicating overall weakness in momentum and trend direction. This combination suggests a cautious outlook for the stock, as all scores fall within the bearish range.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.